about
Timed response to inhaled nitric oxide in pulmonary hypertension.Altered immune phenotype in peripheral blood cells of patients with scleroderma-associated pulmonary hypertensionOverview of current therapeutic approaches for pulmonary hypertension.Effects of Aged Stored Autologous Red Blood Cells on Human Endothelial FunctionAmbrisentan: a review of its use in pulmonary arterial hypertension.Acute respiratory failure mimicking acute respiratory distress syndrome due to parenchymal infiltration by metastatic melanoma.Impact of four times daily dosing of oral treprostinil on tolerability and daily dose achieved in pulmonary hypertension.Not your otitis media 101.A rare presentation of ischemic pseudomembranous colitis due to Escherichia coli O157:H7.Lung Nodules in a Woman With a History of Breast CancerEvaluating Acceptance and Understanding of Risk in the Emergency Department:Are All Risk Statements Created Equally?Effects of aged stored autologous red blood cells on human plasma metabolomeDistinct plasma gradients of microRNA-204 in the pulmonary circulation of patients suffering from WHO Groups I and II pulmonary hypertensionTreatment of exercise pulmonary hypertension improves pulmonary vascular distensibilityLower DLco% identifies exercise pulmonary hypertension in patients with parenchymal lung disease referred for dyspneaActivation of the Metabolic Master Regulator PPARγ: A Potential PIOneering Therapy for Pulmonary Arterial HypertensionPostural changes from ventilatory gas exchange in pulmonary hypertension: Is it a practical solution to a complex question?
P50
Q33805925-C6518D67-92F1-43B7-9757-D27488B81F44Q34250971-B2932631-06AF-4267-81CA-C8985F66755AQ35412362-A51AE9AE-02E9-437F-8F5B-DD92DE0EC05CQ36516529-38B99B8A-9EA1-4652-AF95-70A00EDFD572Q39251587-2E5256BF-FADF-40EE-A0FA-3D39EBE5FC5AQ41181281-61095405-9283-4C04-B5A3-BCF47E396872Q47110884-492F2D6A-1A9F-439A-A571-F255239A45EBQ53281595-7C85553B-7AAC-4539-8F96-82DBABF00998Q54439437-9FEFAF9E-DFDC-4C24-A090-F5A4EEDEDE40Q58841945-E4E56A3C-FAD3-4DF6-941B-BAA5AB4C2C4EQ61387970-E3DDCC9B-B432-4716-836A-534702F06A36Q64073884-2CF208E0-11B8-482B-9EBE-D9EBE4A722A1Q64109605-9EA0ECFE-F6E4-49FC-B114-C6F48ADB2ACAQ89147044-BDE735FF-5F66-4804-8945-F8FD9AFC124CQ90014645-0E58399B-709A-4956-A881-CE2FD64FAACDQ90436104-1AFAC37F-CD30-45C5-B409-6858AFA66C9AQ92898744-41E771E0-ABD7-4AA9-9194-875AD8DD6BED
P50
description
hulumtues
@sq
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Michael G Risbano
@ast
Michael G Risbano
@en
Michael G Risbano
@es
Michael G Risbano
@nl
Michael G Risbano
@sl
type
label
Michael G Risbano
@ast
Michael G Risbano
@en
Michael G Risbano
@es
Michael G Risbano
@nl
Michael G Risbano
@sl
prefLabel
Michael G Risbano
@ast
Michael G Risbano
@en
Michael G Risbano
@es
Michael G Risbano
@nl
Michael G Risbano
@sl
P106
P21
P31
P496
0000-0003-3334-7046